Merck & Co., Inc. Other Non-current Liabilities 2008-2026 | MRK
Beta
What is Merck & Co., Inc.'s current other non-current liabilities?
Merck & Co., Inc. (MRK) annual other non-current liabilities for 2025 was $7.69B, a 18.92% increase from 2024. Merck & Co., Inc. other non-current liabilities for the quarter ending March 31, 2026 was $7.64B.
What was Merck & Co., Inc.'s other non-current liabilities in 2024?
Merck & Co., Inc. annual other non-current liabilities for 2024 was $6.46B, a 26.47% decline from 2023.
What was Merck & Co., Inc.'s other non-current liabilities in 2023?
Merck & Co., Inc. annual other non-current liabilities for 2023 was $8.79B, a 5.63% increase from 2022.
What is Merck & Co., Inc.'s 5-year other non-current liabilities CAGR?
Merck & Co., Inc. other non-current liabilities grew at a compound annual growth rate (CAGR) of 8.98% from FY2020 to FY2025, going from $12.31B to $7.69B over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-9.0%
FY2020
$12.31B
→
FY2025
$7.69B
081213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.69B | +18.9% | 10-K |
| FY2024 | $6.46B | -26.5% | 10-K |
| FY2023 | $8.79B | +5.6% | 10-K |
| FY2022 | $8.32B | -11.8% | 10-K |
| FY2021 | $9.43B | -23.3% | 10-K |
| FY2020 | $12.31B | +2.8% | 10-K |
| FY2019 | $11.97B | -0.6% | 10-K |
| FY2018 | $12.04B | +8.3% | 10-K |
| FY2017 | $11.12B | +30.6% | 10-K |
| FY2016 | $8.51B | +15.9% | 10-K |
| FY2015 | $7.34B | -6.0% | 10-K |
| FY2014 | $7.81B | -4.0% | 10-K |
| FY2013 | $8.14B | -21.2% | 10-K |
| FY2012 | $10.33B | +254.5% | 10-K |
| FY2008 | $2.91B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →